Publication Ethics Policy
Document version 1.2. First version: 16/09/2021. Last review: 01/01/2023.
The Dr. D. Scientific Consulting Publication Ethics Policy is based, in large part, on the guidelines and standards developed by the Committee on Publication Ethics (COPE). The company also endorses:
- Code of Conduct and Best-Practice Guidelines for Journal Editors (Committee on Publication Ethics, 2011), basically following the same adaptation created by PsychOpen;
- Publication Ethics and Publication Malpractice Statement - PsychOpen
- Ethics in Research & Publication (Elsevier)
- Committee on Publication Ethics (COPE)
- Principles of Transparency (COPE)
- Ethical Guidelines for Journal Publication (Elsevier)
- International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
- Declaration of Helsinki for research involving human participants, human material, or human data
- International Council for Laboratory Animal Science (ICLAS)
- Conselho Nacional de Controle de Experimentação Animal - CONCEA - Brazil (Brazilian National Animal Experiment Control Council - CONCEA -)
- Comissões de Ética no Uso de Animais (CEUAs) - Brazil (Brazilian Animal Use Ethics Commissions)
- World Association of Medical Editors (WAME)
When submitting a manuscript to any journal maintained or developed by Dr. D. Scientific Consulting implies that all authors have read and agreed to its content and that the manuscript conforms to The company 's policies. The company remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The relevant duties and expectations of authors, reviewers, and editors of The company are set out below.
Compliance with publication ethics ensures the integrity of scientific publishing and confidence in published articles. Therefore, The company expects all authors to adhere to ethical requirements in preparing their manuscripts.
Authors should observe high standards concerning publication ethics as set out by the Commission on Publication Ethics (COPE). Falsification or fabrication of data, plagiarism, duplicate publication of the authors' work without proper citation, and misappropriation of the work are unacceptable practices. Any cases of ethical misconduct are treated very seriously and will be dealt with following the COPE guidelines.
The company employs a fully double-blind peer-review process where both reviewers and authors remain anonymous throughout the review process. All articles submitted for publication undergo an initial editorial screening. When a submission is considered appropriate, it is sent to two reviewers under the editorial policies and with a minimum quality level. The reviewers will not know the identity of the authors, as any identifying information will be stripped from the document before review.
Once an author submits a paper, the Editor(s) checks the paper's composition and arrangement against The company 's submission guidelines. In particular, we review the presence of required sections and stylizations; that the article is within the scope of The company ; and that it is sufficiently original and topical. If not, the paper may be rejected without being reviewed any further. A designated Editor-in-Chief will take care of the review process from this point onwards. The appointed Editor-in-Chief assigns at least two Referees for manuscript review according to their expertise. The referees shall be experts in the given field, and, if possible, they should not be institutionally or personally associated with the author. Referees are asked to evaluate the manuscript and provide constructive anonymized comments for the author.
Authorship provides credit for a researcher's contributions to a study and carries accountability. Each author is expected to have made substantial contributions to one of the following moments of the manuscript: conception; design of the work; the acquisition, analysis, or interpretation of data; creation of new software used in work; have drafted the work or substantively revised it. Also, it is expected the authors have approved the submitted version (and any substantially modified version that involves the author's contribution to the study); have agreed both be personally accountable for the contributions of the author and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
The company encourages collaboration with colleagues in the locations where the research is conducted and expects their inclusion as co-authors when they fulfill all authorship as mentioned earlier criteria. Contributors who do not meet all criteria for authorship should be listed in the Acknowledgements section.
Authors wishing to make changes to authorship will be asked to explain the reasons to make this change and complete a change of authorship form. However, it is essential to emphasize that changes to authorship cannot be made after the acceptance of a manuscript.
The Cambridge Online Dictionary defines plagiarism as: "the process or practice of using another person's ideas or work and pretending that it is your own". The company considers plagiarism a serious offense. There is a very strict policy towards plagiarism in this journal. Articles are screened for plagiarism before, during, and after publication; if found, they will be rejected at any stage of processing. The company is committed to eliminating manuscripts with possible plagiarism cases from its review and publication process. The company uses different plagiarism detection applications to check each manuscript for potential cases of plagiarism. A plagiarism check is the first step in the manuscript review process. Manuscripts that are found to contain an unacceptable level of similarity with other published works are immediately rejected. Submitted manuscripts should be the original works of the author(s). The company follows COPE guidelines in suspected cases of plagiarism.
Citations manipulation (Fake References):
- The company has a strict policy for fake references. All references will be checked before, during, and after publication, and if found fake or copied from other sources, the paper will be rejected at any stage of processing. The company will check into references cited by the author that are unfamiliar.
- The references should be appropriate, reasonably recent (most within ten years), and credible sources. Authors should cite primary sources from the original research article or database.
- A manuscript should contain only relevant citations. The inclusion of sources that are not relevant to the work is strongly discouraged. Similarly, irrelevant self-citation to increase one's citation is unethical.
- Excessive self-citation, coordinated efforts among several authors to collectively self-cite, gratuitous, and unnecessary citation of articles published in The company to which the paper has been submitted, and any other form of citation manipulation are inappropriate, not ethical behavior.
The company does not accept duplicate submissions. Duplicate submission is when an author simultaneously submits the same or similar manuscripts to two different journals. This includes submitting manuscripts from the same data so that there are no substantial differences in the manuscripts. Duplicate submission also includes the submission of the same/similar manuscript in different languages to different journals. Also, It is unethical to fabricate, manipulate, or falsify data in a manuscript.
ETHICS COMMITTEE APPROVAL ON RESEARCH WITH HUMAN
Ethics approval for research involving human participants, human material, or human data
Research involving human participants, human material, or human data must have been performed following the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Suppose a study has been granted an exemption from requiring ethics approval. In that case, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to the Editor on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, the Editor may contact the ethics committee for further information.
Research on human participants, which includes identifiable human material or identifiable data, requires ethical protection. According to the Declaration of Helsinki issued by the World Medical Association, research on human participants should be formulated in experimental protocols. These should be submitted to independent ethical review boards (ethics committees and institutional review boards) for approval. Additionally, every potential participant should be informed about the "aims, methods, sources of funding, any possible conflicts of interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the study and the discomfort it may entail" and should give consent to participate.
Consent to participate:
- The protection of a patient's right to privacy is essential, and Ethics approval must be sought for research involving human participants. Authors are required to describe in their manuscripts ethics committee approval and participants consent by study design from participants when research involves human participants. Please collect and keep copies of patients' consent forms on which patients or other subjects of your experiments clearly grant permission to publish photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. A statement to the effect that such consent had been obtained must be included in the 'Methods' section of your paper. If necessary, the individual journal Editor(s) may request a copy of any consent forms.
- For all research involving human participants that include details, images, vídeos, biomedical, clinical, and biometric data relating to an individual person, written informed consent for the publication of these details must be obtained from that person (or their parent or legal guardian in the case of children under 18), and a statement to this effect should appear in the manuscript. The manuscript must include a statement that written informed consent for publication was obtained. Authors can use the consent form to obtain consent for publication or a consent form from their own institution or region if appropriate. The consent form must state that the details/images/videos will be freely available on the internet and may be seen by the general public. The consent form must be made available to the Editor if requested and will be treated confidentially. In the case of articles describing human transplantation studies, authors must include a statement declaring that organs/tissues were not obtained from
- vulnerable groups (for example, unconscious patients) where there is the potential for coercion (for instance, prisoners) and must also name the institution(s)/clinic(s)/department(s) via which organs/tissues were obtained. Documentary evidence of consent must be supplied if requested. The final decision on whether consent to publish is required lies with the Editor.
Ethics committee approval:
- All articles dealing with original human or animal data must include a statement on ethics approval in the Materials and Methods section reporting of ethics committee approval and patient consent by study design. This paragraph must contain the name and address of the ethics committee responsible; the protocol name and the number of approving committee that this ethics committee attributed; the name of the Chairperson of the ethics committee (or the person who approved the protocol), the date of approval by the ethics committee, type of consente, data source, and whether the study used data collected as part of a study reported elsewhere were recorded.
- Example of citation of Ethics committee approval in the Materials and Methods section.
- This research has been granted the ethics committee approval for Human or Animal sample use as follows: Ethics: Ethical approval for this study (Ethical Committee N° XXXXX) was provided by the Ethical Committee of (Name of University or Hospital Commitee, City, Country) (Chairperson - Full Name of the person responsible for authorizing the experiment -) on (Date - day, Month, Year).
- Authors are required to describe in their manuscripts ethical approval from an appropriate committee and how the participants consented to the study if they have signed any document in which the research and its outcomes are clearly and well explained, how the researches will use all data and, if the case, the number of the ethics committee approval from the UNIVERSITY or HOSPITAL. In addition, when reporting experiments on people, authors should indicate whether the procedures followed were following the ethical standards of the responsible committee on human experimentation (institutional and national).
- In case the University in which the study was carried out does not demand any official document, or if no formal ethics committee is available, research must have been performed in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. The authors have to explain that and say that all participants have agreed to participate in this study.
A 'participant' is someone who actively provides research data. For example:
- Completes surveys;
- Participates in interviews, discussions or observations;
- Undergoes psychological, physiological, or medical treatment or testing;
- Tests software;
- Grants access to personal collections of records and photographs;
- Is the person from whom tissue has been collected (including blood, urine, saliva, and hair);
- Is identified in a record, e.g., employment record, medical record, education record, membership list, electoral roll;
- Is identified or de-identified in data banks or unpublished human research data, e.g., analysis of existing unpublished data collected by another researcher or collected for a different research project.
RESEARCH INVOLVING ANIMALS
ANIMAL ETHICS COMMITTEES (A.E.C.S)
Authors must describe the Animal Ethics Committee approval when the study is carried out using animals in their manuscripts. Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines and, where available, should have been approved by an appropriate ethics committee. Field studies and other non-experimental research on animals must comply with institutional, national, or international guidelines, and where available, an appropriate ethics committee should have been approved. A statement detailing compliance with relevant guidelines and/or appropriate permissions or licenses must be included in the manuscript.
The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals following the International Council for Laboratory Animal Science (ICLAS) and the Brazilian Conselho Nacional de Controle de Experimentação Animal (CONCEA) ethical guidelines.
A statement detailing compliance with relevant guidelines and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. Suppose a study has been granted an exemption from requiring ethics approval. In that case, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption). The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols inconsistent with commonly accepted norms of animal research. In rare cases, the Editor may contact the ethics committee for further information. For experimental studies involving client-owned animals, authors must also document informed consent from the client or owner and adherence to a high standard (best practice) of veterinary care.
Animal Ethics Committees (A.E.C.s) provide avenues for public participation in the regulation of animal research. A.E.C.s are responsible for approving and monitoring research within Accredited Animal Research Establishments, including carrying out inspections of animals and facilities.
No animal research may be carried out without A.E.C. approval. A.E.C.s must consider and evaluate applications to conduct research based on the researchers' responses to a comprehensive set of questions, including their justification for the research, its likely impact on the animals, and procedures for preventing or alleviating pain and distress.
On behalf of the establishment, A.E.C.s can stop inappropriate research and discipline researchers by withdrawing their research approvals. They can require that adequate care, including emergency care, is provided for animals. They also provide guidance and support to researchers on matters relevant to animal welfare through the preparation of guidelines and disseminating relevant scientific literature. A.E.C.s are responsible for advising establishments on the changes to physical facilities that should be made to provide for the needs of the animals used.
Ethics committee approval:
This research has been granted the ethics committee approval for Human or Animal sample use as follows:
Ethics: Ethical approval for this study (Ethical Committee N° XXXXX) was provided by the Ethical Committee of (Name of University or Hospital Committee, City, Country) (Chairperson - Full Name of the responsible for authorizing the experiment -) on (Date - day, Month, Year).
All research articles undergo thorough double-blind peer review. This usually involves a review by two independent peer reviewers.
All submissions to The company are assessed by an Editor, who will decide whether they are suitable for peer review. An editor is on the author list or has other competing interests regarding a specific manuscript. Another member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. Submissions felt suitable for consideration will be sent for peer review by appropriate independent experts identified by the Handling Editor. Editors will decide based on the reviewers' reports, and authors are sent these reports along with the editorial decision on their manuscript. Authors should note that even in light of one positive report, concerns raised by another reviewer may fundamentally undermine the study and result in the manuscript being rejected. The practice of peer review is to ensure that only good science is published. It is an objective process at the heart of good scholarly publishing and is carried out by all reputable scientific journals. All referees play a vital role in maintaining the high standards Review Policy and all manuscripts are peer-reviewed following the procedure outlined below.
Initial manuscript evaluation
The Editor first evaluates all manuscripts to check their suitability to the AIM and SCOPE of The company , apart from critical issues like Plagiarism and Citation manipulation. It is rare, but an exceptional manuscript can be accepted at this stage. Manuscripts rejected at this stage are insufficiently original, have serious scientific flaws, have poor grammar or English language, or are outside The company 's aims and scope. Those that meet the minimum criteria are normally passed on to at least 2 experts for review.
Type of Peer-Review
The company employs double-blind peer-reviewing, where both the referee and author remain anonymous throughout the process.
Referees are asked to evaluate whether the manuscript is original; methodologically sound; follows appropriate ethical guidelines; has results clearly presented and supports the conclusions, and correctly references previous relevant work. Language correction is not part of the peer-review process, but referees may, if so wish, suggest modifications to the manuscript.
How long does the review process take?
The review processing time might take up to 150 days from the date of receiving the paper. Should the referee's reports contradict one another or a report is unnecessarily delayed, a further expert opinion will be sought. The Editor's decision will be sent to the author with recommendations made by the referees, which usually include verbatim comments by referees. Revised manuscripts might be returned to the initial referees, who may request another manuscript revision.
A final decision to accept or reject the manuscript will be sent to the author and any recommendations made by the referees and may include verbatim comments.
Editor's Decision is final
Referees advise the editor, who is responsible for accepting or rejecting the article.
The company will follow the COPE guidelines outlining how to deal with cases of suspected misconduct.
All research involving humans (including human data and human material) and animals must have been carried out within an appropriate ethical framework (see our research involving animals - Animal Ethics Committees (A.E.C.s) and Ethics approval for research involving human participants, human material, or human data information). If there is suspicion that research has not taken place within an appropriate ethical framework, the Editor may reject a manuscript and may inform third parties, for example, author(s)' institution(s) and ethics committee(s). In cases of proven research misconduct involving published articles or where the scientific integrity of the article is significantly undermined, articles may be retracted.
Corrections, Retractions & Expressions of Concern
In case The company must publish corrections to, or retractions of, articles published in The company , this will be made to maintain the integrity of the academic record. The company applies Committee on Publication Ethics guidelines on corrections, retractions, and expressions of concern in such situations.
Errors in published papers may require a correction in the form of an erratum. Because articles can be read and cited as soon as they are published, any changes after that could potentially impact those who read and cited the earlier version. The company provides authors with an opportunity to review article proofs before publication with the express goal of ensuring the accuracy of the content. Publishing an erratum increases the likelihood that readers will find out about the change and explains the change's specifics. Errata is published on a numbered page and will contain the original article's citation. Cases where these corrections are insufficient to address an error will be dealt with on a case-by-case basis by the Editor-in-Chief. Inadequacies arising from the normal course of new scientific research are not within this scope and will require no correction or withdrawal.
Expressions of Concern
Where substantial doubt arises as to the honesty or integrity of a submitted or published article, it is the Editor-in-Chief's responsibility to ensure that the matter is adequately addressed. The Editor-in-Chief should be promptly informed of the decision of the sponsoring institution, and a retraction should be printed should it be determined that a fraudulent paper was published. Alternatively, the Editor-in-Chief may choose to publish an expression of concern over aspects of the conduct or integrity of the work.
The company endorses the Committee on Publication Ethics (COPE) Retraction Guidelines (CLICK HERE), and also refers to the ICMJE advice on Corrections, Retractions and "Expressions of Concern" as well as on Overlapping Publications. Any alterations to the original article will be described in the note. The original article remains in the public domain, and the subsequent Correction or Retraction will be widely indexed. In the exceptional event that material is considered to infringe certain rights or is defamatory, we may have to remove that material from our site and archive sites. Authors, readers, or organizations who become aware of errors or ethics issues in a published article are encouraged to contact the individual journal in the first instance via the contact details available on The company website. The Editors will consider all reports; additional expert advice may be sought when deciding on the most appropriate course of action. A retraction note titled "Retraction: [article title]" is published in the paginated part of The company 's subsequent issue and listed in the contents list. The online article is preceded by a screen containing the retraction note. To this screen, the link resolves; the reader can then proceed to the article itself. The original article is retained unchanged save for a watermark on the .pdf indicating on each page that it is "retracted."
Article removal: legal limitations
It may be necessary to remove an article from the online database in an extremely limited number of cases. This will only occur where the article is defamatory or infringes others' legal rights, or where the article is, or we have good reason to expect it will be, the subject of a court order, or where the article, if acted upon, might pose a serious health risk. In these circumstances, while the metadata (Title and Authors) will be retained, the text will be replaced with a screen indicating the article has been removed for legal reasons.
The editor is responsible for deciding which of the papers submitted to The company will be published. The editor will evaluate manuscripts without regard to the authors' race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. The decision will be based on the paper's importance, originality, and clarity, and the study's validity and its relevance to The company 's scope. Current legal requirements regarding libel, copyright infringement, and plagiarism should also be considered.
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted paper will not be used by the editor or the editorial board members for their own research purposes without the author's explicit written consent.
Acknowledgement of sources
Editors should use appropriate software to identify cases in which relevant published work referred to in the paper has not been cited in the reference section. The software analysis results should point out whether observations or arguments derived from other publications are accompanied by the respective source. The Editors will notify the author of any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have taken knowledge.
Contribution to editorial decisions
The peer-reviewing process assists the editor and the editorial board in making editorial decisions and may also serve the author in improving the paper.
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and withdraw from the review process.
Any manuscripts received for review must be treated as confidential documents. They must not be disclosed to or discussed with others except as authorized by the editor.
Standards of objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
Acknowledgement of sources
Reviewers should identify cases in which relevant published work referred to in the paper has not been cited in the reference section. They should point out whether the respective source accompanies observations or arguments derived from other publications. Reviewers will notify the editor of any substantial similarity or overlap between the manuscript under consideration and any other published paper they have personal knowledge of.
Disclosure and conflict of interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions associated with the papers.
Authors of original research reports should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
Data access and retention
Authors could be asked to provide the raw data of their study together with the paper for editorial review. They should be prepared to make the data publicly available if practicable. In any event, authors should ensure accessibility of such data to other competent professionals for at least ten years after publication (preferably via an institutional or subject-based data repository or other data center), provided that the confidentiality of the participants can be protected and legal rights concerning proprietary data do not preclude their release.
Originality, plagiarism, and acknowledgement of sources
Authors will submit only entirely original works, and will appropriately cite or quote the work and/or words of others. Publications that have been influential in determining the nature of the reported work should also be cited.
Multiple, redundant or concurrent publication
In general, papers describing essentially the same research should not be published in more than one journal. Submitting the same paper to more than one journal constitutes unethical publishing behavior and is unacceptable.
Manuscripts that have been published as copyrighted material elsewhere cannot be submitted. In addition, manuscripts under review by The company should not be resubmitted to copyrighted publications. However, by submitting a manuscript, the author(s) retain the rights to the published material. In case of publication, they permit the use of their work under a CC-BY license [http://creativecommons.org/licenses/by/4.0/], which allows others to copy, distribute and transmit the work as well as to adapt the work and to make commercial use of it.
Authorship of the paper
Authorship should be limited to those who have contributed significantly to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors.
The corresponding author ensures that all contributing co-authors and no uninvolved persons are included in the author list. The corresponding author will also verify that all co-authors have approved the final version of the paper and have agreed to its submission for publication.
Disclosure and conflicts of interest
All authors should include a statement disclosing any financial or other substantive conflicts of interest that may be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify The company editor or publisher and to cooperate with the editor to retract or correct the paper in the form of an erratum.